Organogenesis Holdings Inc. Quarterly Operating Income (Loss) in USD from Q4 2015 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Organogenesis Holdings Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2015 to Q4 2024.
  • Organogenesis Holdings Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was $10.2M.
  • Organogenesis Holdings Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$1.28M, a 110% decline year-over-year.
  • Organogenesis Holdings Inc. annual Operating Income (Loss) for 2024 was -$1.28M, a 110% decline from 2023.
  • Organogenesis Holdings Inc. annual Operating Income (Loss) for 2023 was $12.5M, a 43.8% decline from 2022.
  • Organogenesis Holdings Inc. annual Operating Income (Loss) for 2022 was $22.3M, a 69.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $10.2M +$11.5M Dec 31, 2024 10-K 2025-02-27
Q3 2024 $6.24M -$1.81M -22.5% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$13.9M -$23.6M -243% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$3.85M +$149K +3.72% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$1.27M -$9.99M -115% Dec 31, 2023 10-K 2025-02-27
Q3 2023 $8.05M +$6.27M +353% Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $9.75M -$2.19M -18.3% Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$4M -$3.87M -3026% Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $8.72M -$11M -55.9% Dec 31, 2022 10-K 2025-02-27
Q3 2022 $1.78M -$14.5M -89.1% Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $11.9M -$11.7M -49.4% Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$128K -$12.7M -101% Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $19.8M -$1.48M -6.99% Dec 31, 2021 10-K 2024-02-29
Q3 2021 $16.3M -$6.54M -28.7% Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $23.6M +$25.8M Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $12.6M +$27.7M Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $21.2M +$23.4M Dec 31, 2020 10-K 2023-03-01
Q3 2020 $22.8M +$31.1M Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$2.25M +$5.07M +69.2% Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$15.1M -$2.96M -24.4% Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$2.15M +$2.33M +52% Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$8.27M +$1.81M +17.9% Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$7.32M +$9.71M +57% Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$12.1M +$7.86M +39.3% Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$4.48M -$2.08M -86.5% Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$10.1M -$7.45M -285% Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$17M -$19.5M -782% Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$20M -$17M -573% Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$2.4M -$1.1M -85% Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$2.62M -$2.6M Sep 30, 2017 10-K 2019-03-18
Q2 2017 $2.5M +$2.5M Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$2.97M -$2.96M Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$1.3M -$1.27M -5060% Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$14.5K* Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$500* Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$15.6K* Mar 31, 2016 10-Q 2017-05-12
Q4 2015 -$25.2K Dec 31, 2015 10-K 2018-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.